Article History
Received: 15 December 2018
Accepted: 2 March 2019
First Online: 13 March 2019
Compliance with ethical standards
:
: RJW receives research funding from Gilead Sciences and Abbvie, has served as a consultant and member of the advisory board for Gilead Sciences, and serves on the speaker’s bureau for Gilead Sciences, Salix, and Bayer. RJW is also funded by an AASLD Foundational Clinical and Translational Research Award in Liver Diseases. GH receives funding from Gilead Sciences. EV reports no conflicts of interest.